Since its inception 25 years ago, Pulmonary Pathology Society has been continuously committed to support education, research and modern clinical practice in pulmonary pathology. In June 2019, Pulmonary Pathology Society Biennial Meeting took place in Dubrovnik, Croatia. This unique meeting of experts in the field of rapidly changing thoracic pathology provided a unique opportunity to attendees from around the globe to expand the knowledge in diagnosis and management of patients with neoplastic and non-neoplastic diseases of the lung, pleura and mediastinum. This series covers selected presented topics including the classification of lung adenocarcinomas and neuroendocrine tumors, challenges and barriers in testing for predictive biomarkers for targeted therapies and immunotherapies, and finally advances in the diagnosis and prognostication of pleural mesothelioma.

Disclosure:
The series “Selected Highlights of the 2019 Pulmonary Pathology Society Biennial Meeting” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Sanja Dacic served as the unpaid Guest Editor for the series.